![PRD_001258 PRD_001258](https://data.pdbj.org/pdbjplus/data/cc/svg/39S.svg) | PRD_001258 | Name: | N-[4-({[(6S)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | Formula: | C29 H37 N9 O12 | Definition date: | 2015-01-14 | Last modified: | 2017-09-14 |
|
![PRD_001140 PRD_001140](https://data.pdbj.org/pdbjplus/data/cc/svg/CTW.svg) | PRD_001140 | Name: | N-(4-fluorobenzoyl)-L-gamma-glutamyl-5-{[(S)-{[(1S)-1,3-dicarboxypropyl]amino}(hydroxy)phosphoryl]oxy}-L-norvaline | Formula: | C22 H29 F N3 O13 P | Definition date: | 2014-12-31 | Last modified: | 2017-09-14 |
|
![PRD_001172 PRD_001172](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001172.svg) | PRD_001172 | Name: | nosiheptide bound form | Formula: | C51 H53 N13 O12 S6 | Definition date: | 2014-12-10 | Last modified: | 2014-12-10 |
|
![PRD_001255 PRD_001255](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001255.svg) | PRD_001255 | Name: | Promothiocin A | Formula: | C36 H47 N11 O8 S2 | Definition date: | 2014-12-10 | Last modified: | 2023-11-03 |
|
![PRD_001208 PRD_001208](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001208.svg) | PRD_001208 | Name: | Stapled peptide (ACE)NWFNITN(DIV)LW(MK8)I(LYV)KKK | Formula: | C106 H165 N27 O28 P | Description: | MODIFIED FRAGMENT OF HIV GLYCOPROTEIN (GP41) | Definition date: | 2014-12-03 | Last modified: | 2014-12-03 |
|
![PRD_001209 PRD_001209](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001209.svg) | PRD_001209 | Name: | Stapled peptide (ACE)NWFNITN(DIV)LW(MK8)IKKKK | Formula: | C103 H161 N25 O22 | Description: | MODIFIED FRAGMENT OF HIV GLYCOPROTEIN (GP41) | Definition date: | 2014-12-03 | Last modified: | 2014-12-03 |
|
![PRD_002118 PRD_002118](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002118.svg) | PRD_002118 | Name: | N-[(4Z)-6-oxo-6-phenylhex-4-enoyl]-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | Formula: | C39 H53 N6 O10 P | Definition date: | 2014-12-03 | Last modified: | 2014-12-03 |
|
![PRD_002126 PRD_002126](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002126.svg) | PRD_002126 | Name: | N-[4-(benzoylamino)butanoyl]-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-allothreoninamide | Formula: | C38 H54 N7 O10 P | Definition date: | 2014-12-03 | Last modified: | 2023-11-03 |
|
![PRD_002127 PRD_002127](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002127.svg) | PRD_002127 | Name: | N-[4-(hydroxymethyl)benzoyl]-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | Formula: | C38 H54 N7 O11 P | Definition date: | 2014-12-03 | Last modified: | 2020-06-27 |
|
![PRD_001254 PRD_001254](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001254.svg) | PRD_001254 | Name: | PL-2 | Formula: | C29 H45 N6 O9 P | Definition date: | 2014-11-19 | Last modified: | 2014-11-19 |
|
![PRD_002115 PRD_002115](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002115.svg) | PRD_002115 | Name: | (3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-24-{(2R)-1-[4-(2-methoxyethyl)piperazin-1-yl]propan-2-yl}-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | Formula: | C69 H125 N13 O13 | Definition date: | 2014-11-12 | Last modified: | 2014-11-12 |
|
![PRD_001080 PRD_001080](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001080.svg) | PRD_001080 | Name: | Peptide inhibitor MPT-DPP-ARG-G-LEU-NH2 | Formula: | C20 H40 N9 O5 S | Definition date: | 2014-10-15 | Last modified: | 2014-10-15 |
|
![PRD_001198 PRD_001198](https://data.pdbj.org/pdbjplus/data/cc/svg/3VH.svg) | PRD_001198 | Name: |
(3aR,5aS,8S,10aS)-1-[(3S,6R,8aS)-1'-[(2S)-2-acetamido-3-(2-chlorophenyl)propanoyl]-5-oxidanylidene-spiro[1,2,3,8a-tetrahydroindolizine-6,2'-pyrrolidine]-3-yl]carbonyl-10-oxidanylidene-2,3,3a,5a,8,10a-hexahydrodipyrrolo[3,2-b:3',1'-f]azepine-8-carboxylic acid | Formula: | C35 H38 Cl N5 O7 | Definition date: | 2014-10-15 | Last modified: | 2023-11-03 |
|
![PRD_002111 PRD_002111](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002111.svg) | PRD_002111 | Name: | 3,5-difluoro-Nalpha-[(2E,5S)-5-methylhept-2-enoyl]-N-[(2S,6aS,12S,13R,15aS,21S,23aS)-2,13,21-trimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-L-phenylalaninamide | Formula: | C41 H56 F2 N6 O8 | Definition date: | 2014-10-08 | Last modified: | 2023-11-03 |
|
![PRD_001191 PRD_001191](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001191.svg) | PRD_001191 | Name: | iCAL36(BRB-K-1) peptide | Formula: | C58 H86 Br N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001192 PRD_001192](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001192.svg) | PRD_001192 | Name: | iCAL36(TFA-K-1) peptide | Formula: | C53 H82 F3 N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001193 PRD_001193](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001193.svg) | PRD_001193 | Name: | iCAL36(FLB-K-1) peptide | Formula: | C58 H86 F N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001194 PRD_001194](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001194.svg) | PRD_001194 | Name: | iCAL36(Ac-K-5) peptide | Formula: | C48 H86 N15 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001195 PRD_001195](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001195.svg) | PRD_001195 | Name: | iCAL36(Ac-K-4) peptide | Formula: | C54 H89 N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001196 PRD_001196](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001196.svg) | PRD_001196 | Name: | iCAL36(Ac-K-3) peptide | Formula: | C55 H89 N16 O15 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001197 PRD_001197](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001197.svg) | PRD_001197 | Name: | iCAL36(Ac-K-1) peptide | Formula: | C53 H85 N16 O16 | Definition date: | 2014-10-01 | Last modified: | 2014-10-01 |
|
![PRD_001222 PRD_001222](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001222.svg) | PRD_001222 | Name: | bicyclic peptide UK601 (bicyclic 1) | Formula: | C59 H101 N24 O17 S4 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
![PRD_001223 PRD_001223](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001223.svg) | PRD_001223 | Name: | bicyclic peptide UK602 (bicyclic 1) | Formula: | C56 H96 N23 O16 S4 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
![PRD_001224 PRD_001224](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001224.svg) | PRD_001224 | Name: | bicyclic peptide UK603 (bicyclic 1) | Formula: | C59 H101 N24 O17 S4 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|
![PRD_001225 PRD_001225](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001225.svg) | PRD_001225 | Name: | bicyclic peptide UK604 (bicyclic 2) | Formula: | C56 H96 N23 O16 S4 | Definition date: | 2014-09-24 | Last modified: | 2014-09-24 |
|